Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0024 USD
Change Today 0.00 / 0.00%
Volume 6.6M
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

oncologix tech inc (OCLG) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/19/15 - $0.01
52 Week Low
06/23/15 - $0.0019
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ONCOLOGIX TECH INC (OCLG)

Related News

No related news articles were found.

oncologix tech inc (OCLG) Related Businessweek News

No Related Businessweek News Found

oncologix tech inc (OCLG) Details

Oncologix Tech, Inc., a diversified medical holding company, manufactures medical devices; and provides personal healthcare services, home medical equipment, and durable medical equipment in the United States. The company operates through three segments: Medical Device Manufacturing, Personal Care Services, and Medical Products and Technologies. The Medical Device Manufacturing segment designs, manufactures, and distributes the Toxygen hardware system with disposables speculums and tubing. Its products are primarily used for bowel preparation prior to medical procedures, such as a colonoscopy and OB/GYN medical procedures; and for individuals seeking health and wellness prevention for good colon health. This segment serves health and wellness spas; endoscopy out-patient clinics; osteopathic physicians; hospital systems- veteran hospitals; skilled nursing homes; assisted living facilities; and individuals with disabilities, such as paraplegic, quadriplegic, and obesity through independent distributors or product re-sellers. The Personal Care Services segment provides non-medical, personal care attendant services, supervised independent living, long-term senior care, and other approved programs. The Medical Products and Technologies segment distributes durable and home medical equipment for respiratory therapy to patients with sleep obstructive disorders or related chronic illnesses. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.

191 Employees
Last Reported Date: 12/15/14
Founded in 1995

oncologix tech inc (OCLG) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $120.0K
Chief Financial Officer and Secretary
Total Annual Compensation: $80.2K
Compensation as of Fiscal Year 2014.

oncologix tech inc (OCLG) Key Developments

Oncologix Tech, Inc. Announces Earnings Results for the Second Quarter and Revenue Results for the Six Months Ended February 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015

Oncologix Tech, Inc. announced earnings results for the second quarter and revenue results for the six months ended February 28, 2015. For the quarter, the company announced revenue of $1,227,877 compared to $974,575 for the same period a year ago. Loss before interest and taxes was $140,934 compared to $187,464 for the same period a year ago. For the six months, the company announced revenues of $2,389,751 up 74% from $1,708,391 for the comparable periods in fiscal 2014. The company provided earnings guidance for the third quarter and full year of fiscal 2015. For the quarter, the company expects to report revenues of $1,289,271, gross profit of $366,888, depreciation and amortization of $4,688, loss before interest and taxes of $102,224. The company announced that it is confident in its ability to move forward with the acquisition and also execute upon its continued acquisition and growth strategy to grow its annualized revenues to $25 million by year-end 2015 with positive EBITDA exceeding $2.6 million.

Oncologix Seeks Acquisitions

Wayne Erwin, Chief Executive Officer of Oncologix Tech, Inc. (OTCPK:OCLG) stated, "We are pleased with the results of our second quarter fiscal 2015". Wayne Erwin further added, "We continue to execute our strategy to focuses on strategic acquisitions and debt reduction, both of which continue to increase Oncologix's market value."

Oncologix Tech, Inc. Reports Earnings Results for the First Quarter Ending November 30, 2014; Provides Earnings Guidance for Second Quarter of 2015

Oncologix Tech, Inc. reported earnings results for the first quarter ending November 30, 2014. For the quarter, the company reported revenues for the first quarter 2015 were $1,161,874, up 60.3% from $724,632 for the comparable period in fiscal 2014. Loss before interest and taxes was $168,025. For the second quarter, the company expected revenues of $1,309,842 and income before interest and taxes was $12,503.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLG:US $0.00 USD 0.00

OCLG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OCLG.
View Industry Companies

Industry Analysis


Industry Average

Valuation OCLG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLOGIX TECH INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at